Emmanuel Osuoha
Emmanuel Osuoha

Dr. Emmanuel Osuoha is a medical writer, SEO content strategist, and Doctor of Optometry (OD). He creates evidence-based, patient-friendly health content that combines clinical accuracy with search engine optimisation (SEO).

NAFDAC Recalls Batch of Sporidex® Suspension for Children Over Quality Concerns

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the voluntary recall of a specific batch of Sporidex® Suspension 125 mg/5 mL, a commonly prescribed antibiotic for children. The recall was initiated by Ranbaxy Nigeria Ltd. (a Sun Pharma Company) after an impurity exceeding the approved specification limit was detected in the product. NAFDAC is advising healthcare professionals, parents, caregivers, pharmacies, and distributors not to use or distribute the affected batch while the recall is ongoing.

Me & You Pharma Takeaways

  • NAFDAC has recalled Sporidex® Suspension 125 mg/5 mL, Batch No. DFG4606A.
  • The recall was initiated after an impurity above the approved limit was detected.
  • Sporidex contains cephalexin, an antibiotic used to treat bacterial infections in children.
  • The affected batch may be less effective and could increase the risk of treatment failure or antibiotic resistance.
  • Parents and caregivers should stop using the affected batch and return it to the point of purchase or a healthcare facility.
  • Healthcare providers and pharmacies have been instructed to remove the affected batch from circulation.

What Happened?

NAFDAC has been notified of the voluntary recall of Sporidex® Suspension 125 mg/5 mL, Batch Number DFG4606A, by its Marketing Authorization Holder, Ranbaxy Nigeria Ltd. (a Sun Pharma Company).

The company initiated the recall as a precautionary measure after identifying an impurity that exceeded the approved specification limit during quality monitoring. According to NAFDAC, the impurity may affect the product’s quality, safety, and stability.

To prevent further distribution, NAFDAC has directed its zonal directors and state coordinators to carry out surveillance and remove the affected batch from pharmacies, hospitals, wholesalers, retailers, and other healthcare facilities across Nigeria.

Why It Matters To Your Health

Sporidex® Suspension contains cephalexin, a cephalosporin antibiotic commonly prescribed for children to treat bacterial infections affecting the throat, ears, skin, teeth, bones, urinary bladder, and kidneys.

When an antibiotic does not meet required quality standards, it may not work as intended. Reduced effectiveness can result in bacteria not being completely eliminated, leading to persistent infections, delayed recovery, worsening illness, or the need for additional treatment.

Another major concern is antimicrobial resistance. If bacteria are exposed to antibiotics that do not deliver the correct quality or potency, they may survive and become more difficult to treat in the future.

NAFDAC also noted that use of the affected batch may increase the likelihood of adverse effects such as nausea, vomiting, diarrhoea, stomach discomfort, and skin rash. Although the recall is precautionary, it is important for parents and healthcare professionals to follow the agency’s advice to avoid unnecessary risks.

What You Can Do

If your child has been prescribed Sporidex® Suspension:

  • Check the bottle to confirm the batch number.
  • If the batch number is DFG4606A, stop using the medicine immediately.
  • Return the affected product to the pharmacy or healthcare facility where it was obtained.
  • Do not dispose of the medicine without guidance from your pharmacist or healthcare provider.
  • Speak with your child’s doctor or pharmacist about an appropriate replacement antibiotic if treatment is still required.
  • Never stop or change an antibiotic treatment without first consulting a healthcare professional unless specifically instructed because of a product recall.

Healthcare facilities, pharmacies, wholesalers, and distributors should immediately quarantine the affected batch and stop further distribution.

Understanding The Issue

Medicine recalls are an essential part of pharmacovigilance and quality assurance systems. They are carried out when manufacturers or regulators identify a problem that could affect a medicine’s safety, quality, or effectiveness.

In this case, the recall involves only one batch (DFG4606A) of Sporidex® Suspension. Other batches are not included in this recall unless future regulatory updates indicate otherwise.

Sporidex® contains cephalexin, an antibiotic belonging to the cephalosporin class. It works by killing bacteria responsible for infections of the ears, throat, skin, urinary tract, bones, and other parts of the body. Like all antibiotics, it should only be used for bacterial infections and not for viral illnesses such as the common cold or influenza.

The impurity detected in the recalled batch exceeded the acceptable specification limit established during quality testing. Pharmaceutical manufacturers routinely monitor products throughout their shelf life to ensure they continue to meet approved standards. When impurities rise above acceptable limits, a recall may be initiated even if no widespread harm has been reported. This precaution helps prevent patients from being exposed to medicines whose quality can no longer be guaranteed.

One important point for parents to understand is that a recalled medicine should not simply be replaced with another antibiotic without medical advice. Different antibiotics treat different bacteria, and using the wrong medicine can contribute to treatment failure and antimicrobial resistance.

This recall also highlights the importance of keeping medicine packaging until treatment is completed. Batch numbers printed on the label or carton help patients determine whether their medicine is affected by a recall.

NAFDAC has stated that the recall information will also be uploaded to the World Health Organization’s Global Surveillance and Monitoring System (GSMS), enabling international monitoring of medicine quality issues.

When To Speak With A Healthcare Professional

Speak with your pharmacist or doctor immediately if:

  • Your child is using Sporidex® Suspension Batch No. DFG4606A.
  • Your child’s infection is not improving after starting treatment.
  • Your child develops new or worsening symptoms while taking the antibiotic.
  • Your child experiences side effects such as persistent vomiting, diarrhoea, skin rash, or stomach pain.
  • You are unsure whether your medicine is part of the recalled batch.

Seek urgent medical attention if your child develops signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, widespread rash, or loss of consciousness.

Join The Me & You Pharma Community

Stay informed with trusted medication updates, drug recall alerts, pharmacist-led advice, and practical health tips. Join the Me & You Pharma community to receive timely safety alerts, understand your medications better, and make informed healthcare decisions for you and your family.

Medical Disclaimer

This content is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment plan.

Have questions about your medications or your child’s treatment? Speak with a trusted healthcare professional or pharmacist for personalized guidance. Me & You Pharma is committed to helping you access reliable medication information and make informed healthcare decisions.

meandyoupharmaprescription savings00kb

← Previous Article NAFDAC Alerts Nigerians as Niger Republic Bans Bulmex Parboiled Rice Over Metallic Contamination Next Article → NAFDAC Intensifies Crackdown on Sachet Alcohol as Illegal Production Continues Despite Nationwide Ban